Skip to main content
NCBI home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1996 May 14;93(10):5037–5042. doi: 10.1073/pnas.93.10.5037

Expansion of polyglutamine repeat in huntingtin leads to abnormal protein interactions involving calmodulin.

J Bao 1, A H Sharp 1, M V Wagster 1, M Becher 1, G Schilling 1, C A Ross 1, V L Dawson 1, T M Dawson 1
PMCID: PMC39402  PMID: 8643525

Abstract

Huntington's disease (HD) is an inherited neurodegenerative disorder associated with expansion of a CAG repeat in the IT15 gene. The IT15 gene is translated to a protein product termed huntingtin that contains a polyglutamine (polyGln) tract. Recent investigations indicate that the cause of HD is expansion of the polyGln tract. However, the function of huntingtin and how the expanded polyGln tract causes HD is not known. We investigate potential protein-protein interactions of huntingtin using affinity resins. Huntingtin from brain extracts is retained on calmodulin(CAM)-Sepharose in a calcium-dependent fashion. We purify rat huntingtin to apparent homogeneity using a combination of DEAE-cellulose column chromatography, ammonium sulfate precipitation, and preparative SDS/PAGE. Purified rat huntingtin does not interact with CAM directly as revealed by 125I-CAM overlay. Huntingtin forms a large CAM-containing complex of over 1,000 kDa in the presence of calcium, which partially disassociates in the absence of calcium. Furthermore, an increased amount of mutant huntingtin from HD patient brains is retained on CAM-Sepharose compared to normal huntingtin from control patient brains, and the mutant allele is preferentially retained on CAM-Sepharose in the absence of calcium. These results suggest that huntingtin interacts with other proteins including CAM and that the expansion of polyGln alters this interaction.

Full text

PDF
5037

Images in this article

5038Fig. 1
on p.5038
5039Fig. 2
on p.5039
5040Fig. 3
on p.5040
5040Fig. 4
on p.5040
5041Fig. 5
on p.5041

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Albin R. L., Tagle D. A. Genetics and molecular biology of Huntington's disease. Trends Neurosci. 1995 Jan;18(1):11–14. doi: 10.1016/0166-2236(95)93943-r. [DOI] [PubMed] [Google Scholar]
  2. Billingsley M. L., Polli J. W., Pennypacker K. R., Kincaid R. L. Identification of calmodulin-binding proteins. Methods Enzymol. 1990;184:451–467. [PubMed] [Google Scholar]
  3. DiFiglia M., Sapp E., Chase K., Schwarz C., Meloni A., Young C., Martin E., Vonsattel J. P., Carraway R., Reeves S. A. Huntingtin is a cytoplasmic protein associated with vesicles in human and rat brain neurons. Neuron. 1995 May;14(5):1075–1081. doi: 10.1016/0896-6273(95)90346-1. [DOI] [PubMed] [Google Scholar]
  4. Duyao M. P., Auerbach A. B., Ryan A., Persichetti F., Barnes G. T., McNeil S. M., Ge P., Vonsattel J. P., Gusella J. F., Joyner A. L. Inactivation of the mouse Huntington's disease gene homolog Hdh. Science. 1995 Jul 21;269(5222):407–410. doi: 10.1126/science.7618107. [DOI] [PubMed] [Google Scholar]
  5. Gutekunst C. A., Levey A. I., Heilman C. J., Whaley W. L., Yi H., Nash N. R., Rees H. D., Madden J. J., Hersch S. M. Identification and localization of huntingtin in brain and human lymphoblastoid cell lines with anti-fusion protein antibodies. Proc Natl Acad Sci U S A. 1995 Sep 12;92(19):8710–8714. doi: 10.1073/pnas.92.19.8710. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Hoogeveen A. T., Willemsen R., Meyer N., de Rooij K. E., Roos R. A., van Ommen G. J., Galjaard H. Characterization and localization of the Huntington disease gene product. Hum Mol Genet. 1993 Dec;2(12):2069–2073. doi: 10.1093/hmg/2.12.2069. [DOI] [PubMed] [Google Scholar]
  7. Hubbard M. J., Klee C. B. Calmodulin binding by calcineurin. Ligand-induced renaturation of protein immobilized on nitrocellulose. J Biol Chem. 1987 Nov 5;262(31):15062–15070. [PubMed] [Google Scholar]
  8. James P., Vorherr T., Carafoli E. Calmodulin-binding domains: just two faced or multi-faceted? Trends Biochem Sci. 1995 Jan;20(1):38–42. doi: 10.1016/s0968-0004(00)88949-5. [DOI] [PubMed] [Google Scholar]
  9. Landwehrmeyer G. B., McNeil S. M., Dure L. S., 4th, Ge P., Aizawa H., Huang Q., Ambrose C. M., Duyao M. P., Bird E. D., Bonilla E. Huntington's disease gene: regional and cellular expression in brain of normal and affected individuals. Ann Neurol. 1995 Feb;37(2):218–230. doi: 10.1002/ana.410370213. [DOI] [PubMed] [Google Scholar]
  10. Li S. H., Schilling G., Young W. S., 3rd, Li X. J., Margolis R. L., Stine O. C., Wagster M. V., Abbott M. H., Franz M. L., Ranen N. G. Huntington's disease gene (IT15) is widely expressed in human and rat tissues. Neuron. 1993 Nov;11(5):985–993. doi: 10.1016/0896-6273(93)90127-d. [DOI] [PubMed] [Google Scholar]
  11. Martin J. B., Gusella J. F. Huntington's disease. Pathogenesis and management. N Engl J Med. 1986 Nov 13;315(20):1267–1276. doi: 10.1056/NEJM198611133152006. [DOI] [PubMed] [Google Scholar]
  12. Nasir J., Floresco S. B., O'Kusky J. R., Diewert V. M., Richman J. M., Zeisler J., Borowski A., Marth J. D., Phillips A. G., Hayden M. R. Targeted disruption of the Huntington's disease gene results in embryonic lethality and behavioral and morphological changes in heterozygotes. Cell. 1995 Jun 2;81(5):811–823. doi: 10.1016/0092-8674(95)90542-1. [DOI] [PubMed] [Google Scholar]
  13. Persichetti F., Ambrose C. M., Ge P., McNeil S. M., Srinidhi J., Anderson M. A., Jenkins B., Barnes G. T., Duyao M. P., Kanaley L. Normal and expanded Huntington's disease gene alleles produce distinguishable proteins due to translation across the CAG repeat. Mol Med. 1995 May;1(4):374–383. [PMC free article] [PubMed] [Google Scholar]
  14. Perutz M. F., Johnson T., Suzuki M., Finch J. T. Glutamine repeats as polar zippers: their possible role in inherited neurodegenerative diseases. Proc Natl Acad Sci U S A. 1994 Jun 7;91(12):5355–5358. doi: 10.1073/pnas.91.12.5355. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Perutz M. Polar zippers: their role in human disease. Protein Sci. 1994 Oct;3(10):1629–1637. doi: 10.1002/pro.5560031002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Ross C. A., McInnis M. G., Margolis R. L., Li S. H. Genes with triplet repeats: candidate mediators of neuropsychiatric disorders. Trends Neurosci. 1993 Jul;16(7):254–260. doi: 10.1016/0166-2236(93)90175-l. [DOI] [PubMed] [Google Scholar]
  17. Ross C. A. When more is less: pathogenesis of glutamine repeat neurodegenerative diseases. Neuron. 1995 Sep;15(3):493–496. doi: 10.1016/0896-6273(95)90138-8. [DOI] [PubMed] [Google Scholar]
  18. Schilling G., Sharp A. H., Loev S. J., Wagster M. V., Li S. H., Stine O. C., Ross C. A. Expression of the Huntington's disease (IT15) protein product in HD patients. Hum Mol Genet. 1995 Aug;4(8):1365–1371. doi: 10.1093/hmg/4.8.1365. [DOI] [PubMed] [Google Scholar]
  19. Sharp A. H., Loev S. J., Schilling G., Li S. H., Li X. J., Bao J., Wagster M. V., Kotzuk J. A., Steiner J. P., Lo A. Widespread expression of Huntington's disease gene (IT15) protein product. Neuron. 1995 May;14(5):1065–1074. doi: 10.1016/0896-6273(95)90345-3. [DOI] [PubMed] [Google Scholar]
  20. Stine O. C., Li S. H., Pleasant N., Wagster M. V., Hedreen J. C., Ross C. A. Expression of the mutant allele of IT-15 (the HD gene) in striatum and cortex of Huntington's disease patients. Hum Mol Genet. 1995 Jan;4(1):15–18. doi: 10.1093/hmg/4.1.15. [DOI] [PubMed] [Google Scholar]
  21. Stott K., Blackburn J. M., Butler P. J., Perutz M. Incorporation of glutamine repeats makes protein oligomerize: implications for neurodegenerative diseases. Proc Natl Acad Sci U S A. 1995 Jul 3;92(14):6509–6513. doi: 10.1073/pnas.92.14.6509. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Strong T. V., Tagle D. A., Valdes J. M., Elmer L. W., Boehm K., Swaroop M., Kaatz K. W., Collins F. S., Albin R. L. Widespread expression of the human and rat Huntington's disease gene in brain and nonneural tissues. Nat Genet. 1993 Nov;5(3):259–265. doi: 10.1038/ng1193-259. [DOI] [PubMed] [Google Scholar]
  23. Trottier Y., Devys D., Imbert G., Saudou F., An I., Lutz Y., Weber C., Agid Y., Hirsch E. C., Mandel J. L. Cellular localization of the Huntington's disease protein and discrimination of the normal and mutated form. Nat Genet. 1995 May;10(1):104–110. doi: 10.1038/ng0595-104. [DOI] [PubMed] [Google Scholar]
  24. Trottier Y., Lutz Y., Stevanin G., Imbert G., Devys D., Cancel G., Saudou F., Weber C., David G., Tora L. Polyglutamine expansion as a pathological epitope in Huntington's disease and four dominant cerebellar ataxias. Nature. 1995 Nov 23;378(6555):403–406. doi: 10.1038/378403a0. [DOI] [PubMed] [Google Scholar]
  25. Walker R. G., Hudspeth A. J., Gillespie P. G. Calmodulin and calmodulin-binding proteins in hair bundles. Proc Natl Acad Sci U S A. 1993 Apr 1;90(7):2807–2811. doi: 10.1073/pnas.90.7.2807. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES